TY - JOUR
T1 - Human papillomavirus prevalence among American indian women of the Great Plains
AU - Lee, Naomi R.
AU - Winer, Rachel L.
AU - Cherne, Stephen
AU - Noonan, Carolyn J.
AU - Nelson, Lonnie
AU - Gonzales, Angela A.
AU - Umans, Jason G.
AU - Buchwald, Dedra
N1 - Funding Information:
Financial support. This work was supported by the National Institutes of Health (NIH) National Cancer Institute (grant number P50CA14811). Additional support for data analysis was provided by the Native Investigator Development Program through the NIH National Institute on Aging (grant number P30AG015292), and by an NIH National Institute of General Medical Sciences Institutional Research and Academic Career Development Award at the University of New Mexico (grant number K12GM088021). Manuscript revisions were supported by the Partnership for Native American Cancer Prevention (NIH National Cancer Institute grant number U54CA143925).
Funding Information:
This study was part of the National Institutes of Health-funded Center for Native Population Health Disparities parent grant. One subproject of the parent grant was to evaluate hrHPV prevalence among American Indian women aged 21–65 years. Thus, we report a thorough analysis of the prevalent hrHPV genotypes present within the convenient sample of American Indian women.
Publisher Copyright:
© 2018 The Author(s). Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.
PY - 2019/2/23
Y1 - 2019/2/23
N2 - Background High-risk human papillomavirus (hrHPV) causes cervical cancer. In the United States, approximately 40% of women aged 14-59 years from all racial and ethnic groups are infected with HPV, and prevalence typically declines with age. However, American Indian (AI) women are insufficiently sampled to permit a population-specific estimate of hrHPV prevalence. Methods Vaginal swabs were self-collected by 698 AI women aged 21-65 years from a tribal community in the Great Plains. We estimated the population prevalence of hrHPV and identified predominant genotypes. Results The combined prevalence of hrHPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68 was 34.8%. HPV-51 (7.6%), HPV-58 (5.3%), HPV-52 (4.3%), HPV-18 (4.3%), and HPV-16 (3.9%) were most prevalent. hrHPV prevalence declined with age, from 42.2% in women aged 21-24 years to 27.9% in women aged 50-65 years. Conclusions HPV-51 was the single most prevalent oncogenic genotype. The combined prevalence of hrHPV among AI women in our sample was high, particularly among women aged 50-65 years, for whom hrHPV prevalence was approximately triple that of other races. Cervical cancer screening efforts should be increased, particularly among women from the community aged 30 years and older.
AB - Background High-risk human papillomavirus (hrHPV) causes cervical cancer. In the United States, approximately 40% of women aged 14-59 years from all racial and ethnic groups are infected with HPV, and prevalence typically declines with age. However, American Indian (AI) women are insufficiently sampled to permit a population-specific estimate of hrHPV prevalence. Methods Vaginal swabs were self-collected by 698 AI women aged 21-65 years from a tribal community in the Great Plains. We estimated the population prevalence of hrHPV and identified predominant genotypes. Results The combined prevalence of hrHPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68 was 34.8%. HPV-51 (7.6%), HPV-58 (5.3%), HPV-52 (4.3%), HPV-18 (4.3%), and HPV-16 (3.9%) were most prevalent. hrHPV prevalence declined with age, from 42.2% in women aged 21-24 years to 27.9% in women aged 50-65 years. Conclusions HPV-51 was the single most prevalent oncogenic genotype. The combined prevalence of hrHPV among AI women in our sample was high, particularly among women aged 50-65 years, for whom hrHPV prevalence was approximately triple that of other races. Cervical cancer screening efforts should be increased, particularly among women from the community aged 30 years and older.
KW - American Indians
KW - genotype distribution
KW - human papillomavirus (HPV)
KW - human papillomavirus vaccination
KW - self-sampling
UR - http://www.scopus.com/inward/record.url?scp=85062030398&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062030398&partnerID=8YFLogxK
U2 - 10.1093/infdis/jiy600
DO - 10.1093/infdis/jiy600
M3 - Article
C2 - 30321371
AN - SCOPUS:85062030398
SN - 0022-1899
VL - 219
SP - 908
EP - 915
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 6
ER -